Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$0.52 - $1.0 $56,312 - $108,293
-108,293 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$1.03 - $1.41 $111,541 - $152,693
108,293 New
108,293 $141,000

Others Institutions Holding NMTR

About 9 METERS BIOPHARMA, INC.


  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.